546 related articles for article (PubMed ID: 26598975)
1. A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases.
Eram MS; Shen Y; Szewczyk M; Wu H; Senisterra G; Li F; Butler KV; Kaniskan HÜ; Speed BA; Dela Seña C; Dong A; Zeng H; Schapira M; Brown PJ; Arrowsmith CH; Barsyte-Lovejoy D; Liu J; Vedadi M; Jin J
ACS Chem Biol; 2016 Mar; 11(3):772-781. PubMed ID: 26598975
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation.
Fong JY; Pignata L; Goy PA; Kawabata KC; Lee SC; Koh CM; Musiani D; Massignani E; Kotini AG; Penson A; Wun CM; Shen Y; Schwarz M; Low DH; Rialdi A; Ki M; Wollmann H; Mzoughi S; Gay F; Thompson C; Hart T; Barbash O; Luciani GM; Szewczyk MM; Wouters BJ; Delwel R; Papapetrou EP; Barsyte-Lovejoy D; Arrowsmith CH; Minden MD; Jin J; Melnick A; Bonaldi T; Abdel-Wahab O; Guccione E
Cancer Cell; 2019 Aug; 36(2):194-209.e9. PubMed ID: 31408619
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a Potent, Selective, and Cell-Active Dual Inhibitor of Protein Arginine Methyltransferase 4 and Protein Arginine Methyltransferase 6.
Shen Y; Szewczyk MM; Eram MS; Smil D; Kaniskan HÜ; de Freitas RF; Senisterra G; Li F; Schapira M; Brown PJ; Arrowsmith CH; Barsyte-Lovejoy D; Liu J; Vedadi M; Jin J
J Med Chem; 2016 Oct; 59(19):9124-9139. PubMed ID: 27584694
[TBL] [Abstract][Full Text] [Related]
4. Development of Potent Type I Protein Arginine Methyltransferase (PRMT) Inhibitors of Leukemia Cell Proliferation.
Wang C; Jiang H; Jin J; Xie Y; Chen Z; Zhang H; Lian F; Liu YC; Zhang C; Ding H; Chen S; Zhang N; Zhang Y; Jiang H; Chen K; Ye F; Yao Z; Luo C
J Med Chem; 2017 Nov; 60(21):8888-8905. PubMed ID: 29019697
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a First-in-Class Protein Arginine Methyltransferase 6 (PRMT6) Covalent Inhibitor.
Shen Y; Li F; Szewczyk MM; Halabelian L; Park KS; Chau I; Dong A; Zeng H; Chen H; Meng F; Barsyte-Lovejoy D; Arrowsmith CH; Brown PJ; Liu J; Vedadi M; Jin J
J Med Chem; 2020 May; 63(10):5477-5487. PubMed ID: 32367723
[TBL] [Abstract][Full Text] [Related]
6. Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylation.
Maron MI; Casill AD; Gupta V; Roth JS; Sidoli S; Query CC; Gamble MJ; Shechter D
Elife; 2022 Jan; 11():. PubMed ID: 34984976
[TBL] [Abstract][Full Text] [Related]
7. A patent review of arginine methyltransferase inhibitors (2010-2018).
Li X; Wang C; Jiang H; Luo C
Expert Opin Ther Pat; 2019 Feb; 29(2):97-114. PubMed ID: 30640571
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of type I PRMT and PARP inhibitors against non-small cell lung cancer cells.
Dominici C; Sgarioto N; Yu Z; Sesma-Sanz L; Masson JY; Richard S; Raynal NJ
Clin Epigenetics; 2021 Mar; 13(1):54. PubMed ID: 33691794
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss.
Fedoriw A; Rajapurkar SR; O'Brien S; Gerhart SV; Mitchell LH; Adams ND; Rioux N; Lingaraj T; Ribich SA; Pappalardi MB; Shah N; Laraio J; Liu Y; Butticello M; Carpenter CL; Creasy C; Korenchuk S; McCabe MT; McHugh CF; Nagarajan R; Wagner C; Zappacosta F; Annan R; Concha NO; Thomas RA; Hart TK; Smith JJ; Copeland RA; Moyer MP; Campbell J; Stickland K; Mills J; Jacques-O'Hagan S; Allain C; Johnston D; Raimondi A; Porter Scott M; Waters N; Swinger K; Boriack-Sjodin A; Riera T; Shapiro G; Chesworth R; Prinjha RK; Kruger RG; Barbash O; Mohammad HP
Cancer Cell; 2019 Jul; 36(1):100-114.e25. PubMed ID: 31257072
[TBL] [Abstract][Full Text] [Related]
10. Chemical probes for protein arginine methyltransferases.
Li ASM; Li F; Eram MS; Bolotokova A; Dela Seña CC; Vedadi M
Methods; 2020 Mar; 175():30-43. PubMed ID: 31809836
[TBL] [Abstract][Full Text] [Related]
11. A First-in-Class, Highly Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 6.
Shen Y; Li F; Szewczyk MM; Halabelian L; Chau I; Eram MS; Dela Seña C; Park KS; Meng F; Chen H; Zeng H; Dong A; Wu H; Trush VV; McLeod D; Zepeda-Velázquez CA; Campbell RM; Mader MM; Watson BM; Schapira M; Arrowsmith CH; Al-Awar R; Barsyte-Lovejoy D; Kaniskan HÜ; Brown PJ; Vedadi M; Jin J
J Med Chem; 2021 Apr; 64(7):3697-3706. PubMed ID: 33591753
[TBL] [Abstract][Full Text] [Related]
12. Kinetic mechanism of protein arginine methyltransferase 6 (PRMT6).
Obianyo O; Thompson PR
J Biol Chem; 2012 Feb; 287(8):6062-71. PubMed ID: 22219200
[TBL] [Abstract][Full Text] [Related]
13. Histone H4K20 monomethylation enables recombinant nucleosome methylation by PRMT1 in vitro.
Li ASM; Homsi C; Bonneil E; Thibault P; Verreault A; Vedadi M
Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194922. PubMed ID: 36822575
[TBL] [Abstract][Full Text] [Related]
14. Kinetic mechanism of protein arginine methyltransferase 1.
Obianyo O; Osborne TC; Thompson PR
Biochemistry; 2008 Sep; 47(39):10420-7. PubMed ID: 18771293
[TBL] [Abstract][Full Text] [Related]
15. Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance.
Zhu Y; Xia T; Chen DQ; Xiong X; Shi L; Zuo Y; Xiao H; Liu L
Drug Resist Updat; 2024 Jan; 72():101016. PubMed ID: 37980859
[TBL] [Abstract][Full Text] [Related]
16. Small Molecule Inhibitors of Protein Arginine Methyltransferases.
Hu H; Qian K; Ho MC; Zheng YG
Expert Opin Investig Drugs; 2016; 25(3):335-58. PubMed ID: 26789238
[TBL] [Abstract][Full Text] [Related]
17. Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer.
Shailesh H; Zakaria ZZ; Baiocchi R; Sif S
Oncotarget; 2018 Nov; 9(94):36705-36718. PubMed ID: 30613353
[TBL] [Abstract][Full Text] [Related]
18. Protein arginine methyltransferases and cancer.
Yang Y; Bedford MT
Nat Rev Cancer; 2013 Jan; 13(1):37-50. PubMed ID: 23235912
[TBL] [Abstract][Full Text] [Related]
19. Independent transcriptomic and proteomic regulation by type I and II protein arginine methyltransferases.
Maron MI; Lehman SM; Gayatri S; DeAngelo JD; Hegde S; Lorton BM; Sun Y; Bai DL; Sidoli S; Gupta V; Marunde MR; Bone JR; Sun ZW; Bedford MT; Shabanowitz J; Chen H; Hunt DF; Shechter D
iScience; 2021 Sep; 24(9):102971. PubMed ID: 34505004
[TBL] [Abstract][Full Text] [Related]
20. The C. elegans PRMT-3 possesses a type III protein arginine methyltransferase activity.
Takahashi Y; Daitoku H; Yokoyama A; Nakayama K; Kim JD; Fukamizu A
J Recept Signal Transduct Res; 2011 Apr; 31(2):168-72. PubMed ID: 21385054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
